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ABSTRACT
Objective: The purpose of the study was to assess the effects of Escherichia coli STa (heat stable)
toxin on isolated human myometrial response to oxytocin.
Methods: One hundred and sixteen muscle strips were obtained from the lower uterine segment
of 42 women undergoing cesarean section at term. Amniotic membranes and decidua were ex-
cluded. Uterine contractility in response to cumulative doses of E. coli STa toxin was recorded, as
well as uterine response to cumulative doses of oxytocin before and after incubation with STa toxin
or vehicle. The 50th percentile effective oxytocin concentration (EC50) of muscle strips with and
without spontaneous activity before and after the incubation with STa toxin or vehicle was calcu-
lated. A paired test was used for comparison.
Results: Muscle strips with and without spontaneous activity responded to cumulative doses of
oxytocin before and after the incubation with STa toxin or vehicle. No differences in contraction
force, duration, or frequency were noted between the groups (P > 0.05). Furthermore, this toxin
was not able to induce uterine contractility when tested alone.
Conclusions: The inability of this toxin to affect myometrial response to oxytocin in this study may
be due to the absence of amnion cells, chorion, or decidua. Other possible explanations for the lack
of response are discussed. Infect. Dis. Obstet. Gynecol. 6:230-234, 1998. (C) 1998 Wiley-Liss, Inc.
KEY WORDS
Escherichia coli; myometrium; oxytocin; premature labor; infection
he incidence of urogenital infections during
pregnancy has been well established, 1,2 and
their association with preterm delivery reported.3,4
Several authors have suggested a relationship be-
tween maternal infection, preterm rupture ofmem-
branes, and prematurity.5-7 Some microorganisms
and bacterial products isolated from women with
premature rupture of membranes and chorioamni-
onitis have been shown to stimulate prostaglandin
synthesis.8-1 These substances may induce or po-
tentiate contractility of the pregnant uterus as well
as other smooth muscles. Romero et al. found that
several lyophilized bacteria, including two strains
of Escherichia coli, were able to induce the synthesis
of prostaglandins by human amnion cells. 11,1z Nev-
ertheless, we have not found reports of the effects
of either E. coli or its products (e.g., heat stable
[STa] toxin) on isolated human myometrial con-
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Fig. I. Analog tracing of the effect of the cumulative addition of oxytocin on the contractility of isolated human myometrial
strips with and without spontaneous activity after and before incubation with toxin or vehicle. Doses of agonist were added
at the points indicated by arrows. Note high potassium stimulus at the beginning and at the end of each experiment. Incubation
time is indicated by an asterisk.
tractility. The present study was conducted to as-
sess the possible effects of E. coli STa toxin on
oxytocin-stimulated human myometrium.
SUBJECTS AND METHODS
Human myometrial samples were collected during
elective cesarean section at term of nonlaboring
patients whose membranes were intact. These
women were informed of the study, which was ap-
proved by the institutional review board. Only
those who gave written consent were included. A
single 2.0-cm long full-thickness strip of myome-
trium was removed from the upper margin of the
incision after delivery. The tissue was immediately
immersed in ice-cold salt solution. After separating
the amnion or serosa if present, two to three strips
of circular muscle (3 x 3 x 12 mm) were carefully
cut from the middle portion of the sample under
magnification (12x). The muscle strips were tied at
each end with 4.0 silk thread and placed in a 10-
mL organ bath vertically within one hour of sur-
gery. The salt solution contained (in millimolars):
3.75 potassium chloride, 120.0 sodium phosphate,
1.0 calcium chloride, 21.0 sodium bicarbonate, 1.25
sodium phosphate, 1.0 magnesium chloride, and
10.0 glucose. The solution was aerated with 95%
oxygen and 5% carbon dioxide, maintaining a pH
of 7.4 +_ 0.5 at 37 C. Isometric contraction was
recorded with a polygraph (Grass Instruments,
Quincy, MA) using a FT-03 transducer. An initial
resting force of 1.0 g was given, allowing 30 min. to
equilibrate. During this period the tissue was
washed twice every 15 min. As soon as the baseline
force restabilizcd, a single dose of potassium chlo-
ride was added to the bath, elevating its concen-
tration to 40 raM, and 5 min. of muscle response
were recorded at the beginning and at the end of
each experiment. Only muscle strips that re-
sponded to this challenge were included. After a
30-rain. period of registered contractility, the strips
were separated into two groups according to the
presence or absence of spontaneous uterine activ-
ity.
In the first series of experiments, cumulative
dose-response curves to oxytocin and E. coli STa
toxin (Sigma Co., St. Louis, MO) were assessed. 13
Nine cumulative doses of STa toxin ranging from
0.1 to 19.2 nM were tested. A different group of
strips without spontaneous activity was challenged
with seven cumulative doses of oxytocin ranging
from 0.1 to 10.0 ng.
In the experimental protocol, three cumulative
doses of oxytocin (X 2.38 10-l M, Y 1.4
10-9 M, Z 6.56 10-9 M) that corresponded ap-
proximately to the initial (25%), middle (50%), and
final (90-100%) part of the first dose-response
curves, respectively, were added before and after
the incubation of the muscle strips with 1.0 ng of
STa toxin14 for 30 min. (Fig. 1). The tissue was
washed twice, and the same dose of STa toxin (1.0
ng) or vehicle was added back to the bath. The
selection of vehicle or STa toxin was made ran-
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Fig. 2. Dose-response curves to oxytocin. Tissue with spontaneous activity. A Percent change (A) from the maximal
contraction produced by oxytocin before (solid line) and in the presence of vehicle (broken line). B Before (solid line) and
in the presence of toxin (broken line) (X + SE).
domly (computerized distribution using Latin
squared method). The second and third oxytocin
doses were applied until no further increase in ten-
sion was observed. The volume of the drugs did
not exceed 0.2 mL. The average contraction force
that developed within 10 rain. of the maximum
contractile response was measured and divided by
tissue weight. Frequency was recorded as the num-
ber of contractions, and duration was registered as
the time from the beginning to the end of each
contraction in this same period of time. A change in
the resting tone excluded the strip from experi-
mental protocols. Several samples exposed to these
conditions were sent for histological analysis, and
their measurements were not included.
Statistical Analysis
Each strip was considered its own control. The
oxytocin concentration producing half maximal re-
sponse (EC50) was used for comparison. A two-
tailed paired t test (alfa 0.05) was used.
RESULTS
The clinical profiles, of the patients who donated
tissue for the study revealed a mean gestational age
of 38.4 + 1.5 weeks; all patients were nonlaboring
patients with intact membranes. Indications for ce-
sarean delivery included elective repeat cesarean in
28 patients and malpresentation in 14. tn the elec-
tive repeat group, the primary cesarean section was
indicated because of cephalopelvic disproportion in
eight, malpresentation in nine, macrosomia in six,
chorioamnionitis in two, and fetal distress in three.
Nine of 14 patients with malpresentation were nul-
liparous. Of a total of 116 myometrial strips ob-
tained from these patients, 103 responded to the
potassium chloride challenge. Sixty five percent of
the strips developed spontaneous activity. No
changes in resting tone were registered in any
group. The ECs0 of oxytocin in tissue with and
without spontaneous activity was calculated as 6.67
1.1 x 10-1 M (n 8) and 7.25 ___
0.8 x 10-9 M (n
8), respectively. Cumulative doses of STa toxin
were administered to several strips, and no change
in uterine contractility was noted (n 10).
In the experimental protocol, tissue with spon-
taneous activity after the addition of oxytocin in-
creased contraction force before (ECso 6.6 __+ 1.7 x
10-1 M) and after incubation with vehicle (ECs0
6.5 1.6 x 10-1 M, P > 0.05, n 9, Fig. 2-A). In the
same group, incubation with STa toxin demon-
strated an ECs0 of 6.5 + 1.4 x 10-1 M (before) and
6.7 +__ 1.9 x 10-
M (after, n 26, P > 0.05, Fig.
2-B). Frequency and duration of contractions in
these groups were not different. In myometrial
strips without spontaneous activity, contraction
force induced by oxytocin after incubation of ve-
hicle was slightly lower than before (1.2 ___
0.4 x
10-9 VS. 1.18 + 0.3 x 10-9 M), but the difference was
not statistically significant (P > 0.05, n 10, Fig.
3-A). Contraction force, frequency, and duration of
contractions induced by oxytocin after the incuba-
tion with toxin were not statistically different (be-
fore 1.19 ___
0.6 x 10-9, after 1.21 ___
0.5 x 10-9 M,
P > 0.05, n 27, Fig. 3-B).
No histopathologic changes of the myometrial
strips exposed to this toxin or vehicle were ob-
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Fig. 3. Dose-response curves to oxytocin. Tissue without spontaneous activity./, Percent from the maximal contraction
induced by oxytocin before (solid line) and in the presence of a vehicle (broken line). B Before (solid line) and in the presence
of toxin (broken line) (X + SE).
served, and the presence of serosa, decidua, or am-
nion cells was excluded.
DISCUSSION
Clinical profiles of patients who donated tissue for
this study, including those who did not respond to
high potassium, were quite uniform. An estimated
88% of the myometrial strips obtained .from these
patients were considered viable judging from their
ability to contract with a high-potassium stimulus.
As reported previously, approximately half of the
strips used in these experiments developed spon-
taneous activity, and the maximal mean tension
developed was our greatest source of variability.
This has been attributed to the differences in total
smooth muscle content of the lower uterine seg-
ment strips obtained through this technique,
is
Therefore, we considered each muscle strip to be
its own control.
Cumulative dose-response curves to E. coli STa
toxin revealed that the toxin was not able to induce
contractility in strips without spontaneous activity,
and no changes were seen when spontaneous ac-
tivity was present. A wide range of toxin doses
above and below the dose that produces symptoms
in humans was tested (1.0 ng per 10 mL). 16’7 In
order to exclude whether the lack of response was
because not enough time was given to the toxin to
act or because the sample was obtained from non-
laboring patients, oxytocin-induced uterine con-
tractions before and after incubation with toxin
were registered. In this series of experiments, cu-
mulative dose-response curves to oxytocin were
obtained and a ECso was calculated for strips with
and without spontaneous activity. In the experi-
mental protocols, both groups of myometrial strips
were incubated with toxin or vehicle, and the mean
of maximal tension developed in response to three
cumulative doses of oxytocin after incubation did
not differ from controls before incubation (Figs.
and 2). Analysis of frequency and duration of the
contractions revealed no differences between the
groups either. The experiments carried out with
vehicle assured that no changes in response to oxy-
tocin were present during the experimental proto-
col. Damage to the tissue and presence of amnion,
chorion, or decidua was excluded histologically.
The results from these experiments suggest that
the incubation of this tissue with STa toxin did not
affect the ability of isolated human myometrium
strips to contract in response to oxytocin under
these conditions. Furthermore, the toxin was not
able induce contractility in strips without sponta-
neous activity over a wide range of doses tested.
The inability of this tissue to respond to STa toxin
in the present study may be explained by the ab-
sence of amnion, chorion, or decidual cells. As
demonstrated by Romero et al., lyophilized bacte-
ria can produce mediators (e.g., prostaglandins, in-
terleukin-1, and tumor necrosis factor) from sur-
rounding contiguous tissues that can trigger myo-
metrial activity. Therefore, the use of lyophilized
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E. coli or STa toxin could affect uterine contractil-
ity when amnion or decidua are present.
Other possibilities for the lack of effect of this
toxin seen in these experiments may include the
absence of STa receptors in the tissue. Schulz and
coworkers have designated guanylyl cyclase as a
heat stable enterotoxin receptor.
18 These entero-
toxin receptors have been described in small bowel
smooth muscle 19 and liverz but not in uterine
myometrium. Studies that could answer this ques-
tion were not done, because without ahy apparent
effect of this toxin on isolated human myometrium,
isolation of these receptors appeared not to be in-
dicated.
These results confirm the importance of con-
tiguous tissues (amnion, chorion, and decidua) in
mediating an increase of uterine response and their
possible role in the initiation of labor in patients
with concomitant infection. In order to better un-
derstand how these events happen, it appears nec-
essary to perform in vitro studies that include myo-
metrium with decidua or amniotic membranes to
determine if the lack of effect is solely due to the
absence of these surrounding tissues or because
this toxin has no inherent effect on the contractility
of human pregnant uterus.
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